LEP and cancer: LPrA-2, a fragment containing leptin site II and corresponding to amino acids 70–95 of human leptin, binds specifically and with high affinity to ObR and, acting as a leptin antagonist, inhibits leptin-related effects in breast cancer and other cancer types [115].